Efficacy and Safety of Synera in Osteoarthritis Pain

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

February 28, 2015

Conditions
Knee Osteoarthritis
Interventions
DRUG

Synera

70 mg lidocaine/ 70 mg tetracaine topical patch applied once for 12 hours

DRUG

Inactive patch

placebo patch applied once for 12 hours

Trial Locations (1)

60611

Northwestern University, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Nuvo Research Inc.

INDUSTRY

lead

Thomas J. Schnitzer

OTHER

NCT01654302 - Efficacy and Safety of Synera in Osteoarthritis Pain | Biotech Hunter | Biotech Hunter